Back to Directory
GenoME Diagnostics
Northern Ireland
Founded 2020
DNA methylation blood tests for ovarian and pancreatic cancers
GenoME Diagnostics is a biotechnology company developing molecular blood tests for cancer detection and monitoring.
Its liquid biopsy platform identifies DNA methylation and fragmentomic biomarkers, combining them into multiplexed droplet digital PCR assays. Its lead test targets ovarian cancer recurrence and monitoring, while a separate programme is developing an early pancreatic cancer test.
The company also explores diagnostic partnerships for biomarker discovery, patient stratification and disease monitoring in other indications.